[Development and clinical assessment of isolated pelvic perfusion].
暂无分享,去创建一个
Y. Kondo | T. Miyashita | T. Kumazaki | S. Murata | H. Tajima | P. Niggemann | R. Kimata | Yutaka Abe | Y. Komada | Kazuhiro Furukawa | Yoshiyuki Oi | Hideaki Takasaki
[1] H. Wanebo,et al. A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion , 1999, Cancer Chemotherapy and Pharmacology.
[2] H. Wanebo,et al. Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. , 1993, Archives of surgery.
[3] A. Wile,et al. Hyperthermic pelvic isolation-perfusion in the treatment of refractory pelvic cancer. , 1987, Archives of surgery.
[4] A. Monaco,et al. Treatment of malignant pelvic tumors by extracorporeal perfusion with chemotherapeutic agents. , 1959, The New England journal of medicine.
[5] R. F. Ryan,et al. Chemotherapy of Cancer: Regional Perfusion Utilizing an Extracorporeal Circuit , 1958, Annals of surgery.